FDA Approves Sodium Oxybate (Xyrem) for Pediatric Narcolepsy FDA Approves Sodium Oxybate (Xyrem) for Pediatric Narcolepsy

The FDA has approved expanded labeling for sodium oxybate (Xyrem) to include treatment of cataplexy or excessive daytime sleepiness in pediatric narcolepsy.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Family Medicine/Primary Care News Alert Source Type: news